Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS
· Delayed Price · Currency is USD
0.5400
+0.0283 (5.53%)
May 20, 2025, 4:00 PM EDT
Mosaic ImmunoEngineering Company Description
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies.
Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Mosaic ImmunoEngineering, Inc.
| Country | United States |
| Founded | 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Steven King |
Contact Details
Address: 9114 Adams Avenue Huntington Beach, Delaware 92646 United States | |
| Phone | 657-208-0890 |
| Website | mosaicie.com |
Stock Details
| Ticker Symbol | CPMV |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US61945M1018 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Steven W. King | Chairman of the Board, President and Chief Executive Officer |
| Paul J. Lytle CPA | Executive Vice President, Chief Financial Officer, Secretary and Director |
| Joseph S. Shan M.P.H. | Head of Clinical Operations |
| Dr. Marvin R. Garovoy M.D. | Head of Medical Immuno-Oncology |
| Cyril Empig Ph.D. | Head of Vaccine Development |